The impact of laparoscopic vs open primary colon resection on long-term outcomes after subsequent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for metachronous peritoneal metastasis
- PMID: 40379853
- DOI: 10.1007/s00464-025-11798-y
The impact of laparoscopic vs open primary colon resection on long-term outcomes after subsequent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for metachronous peritoneal metastasis
Abstract
Background: Several factors have been known to correlate with the early and long-term outcomes of patients undergoing CRS/HIPEC. However, the relation between surgical approach (open vs laparoscopic colectomy) at the index colectomy and oncological outcomes following CRS/HIPEC have not been studied.
Methods: Patients who underwent CRS/HIPEC after previous colectomy for colorectal cancer with peritoneal metastases from 2015 to 2022 were identified from a prospectively maintained database of peritoneal surface malignancies and were divided into two groups according to the primary colectomy approach open or laparoscopic colectomy. Operative and 30-day outcomes were compared between groups, as well as survival outcomes.
Results: A total of 159 patients met inclusion criteria, of those 101 patients were in the open group and 58 patients were in the laparoscopic group. Both groups had similar demographics and comorbidities. TNM staging at index colectomy was similar between the groups as well as peritoneal cancer index (PCI) score for CRS/HIPEC surgery; however, there was more upper jejunal disease involvement in the laparoscopic group compared with the open group (45.5% vs. 22%, p = 0.004) and shorter mean duration of surgery (4.1 vs. 4.69 [hour], p = 0.004). For the laparoscopic and open colectomy groups, respectively, estimated median disease-free survival (DFS) was 25.9 months (95%CI 0-68.1) vs. 9.9 months (95%CI 1.4-12.6) (p < 0.001). In a multivariable analysis the surgical approach of the index colectomy was independently associated with DFS.
Conclusion: Performing CRS HIPEC for metachronous peritoneal metastasis following laparoscopic colectomy may be associated with favorable perioperative and survival outcomes.
Keywords: Colorectal; Cytoreducive surgery; HIPEC; Laparoscopic colectomy; PCI; Peritoneal metastasis.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Disclosure: Yehonatan Nevo, Dan Assaf, Arielle Jacover, Ephraim Katz, Almog Ben-Yaacov, David Hazzan, Shachar Laks, Mohammad Adileh, and Aviram Nissan have no conflicts of interest or financial ties to disclose.
Similar articles
-
Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases.World J Surg Oncol. 2025 Jul 23;23(1):297. doi: 10.1186/s12957-025-03923-x. World J Surg Oncol. 2025. PMID: 40702489 Free PMC article.
-
Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal Metastases.J Am Coll Surg. 2025 Jul 1;241(1):28-37. doi: 10.1097/XCS.0000000000001355. Epub 2025 Jun 13. J Am Coll Surg. 2025. PMID: 39945444
-
The role of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in ovarian carcinoma: where do we stand today? A comprehensive review and clinical insights from a leading oncology center in India.World J Surg Oncol. 2025 Jun 11;23(1):232. doi: 10.1186/s12957-025-03869-0. World J Surg Oncol. 2025. PMID: 40500703 Free PMC article. Review.
-
Postoperative leukopenia after cytoreductive surgery and hypertherm intraperitoneal chemotherapy for colorectal carcinomatosis- causes and implication on outcomes in a population-based study.World J Surg Oncol. 2025 Apr 29;23(1):173. doi: 10.1186/s12957-025-03821-2. World J Surg Oncol. 2025. PMID: 40301901 Free PMC article.
-
Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.Cancer Treat Rev. 2013 Jun;39(4):321-7. doi: 10.1016/j.ctrv.2012.11.003. Epub 2012 Dec 12. Cancer Treat Rev. 2013. PMID: 23244778
References
-
- Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, Mukoyama S, Yasuda S, Tajima T, Makuuchi H, Murayama C (2003) Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 50:1362–1366 - PubMed
-
- Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, Saltz L, Punt CJA, Koopman M, Tournigand C, Tebbutt NC, Diaz-Rubio E, Souglakos J, Falcone A, Chibaudel B, Heinemann V, Moen J, De Gramont A, Sargent DJ, Grothey A (2016) Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol 17:1709–1719 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous